Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years
Clinical trial NCT00538434 · COMPLETED
Trial details
- NCT number
- NCT00538434
- Sponsor
- Ception Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2009-10-01
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.